
Global Prenatal Testing and Newborn Screening Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Prenatal Testing and Newborn Screening market size will reach US$ million by 2031.
Prenatal testing is performed on the mother during pregnancy. Newborn screening is performed after the baby is born.
United States market for Prenatal Testing and Newborn Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Prenatal Testing and Newborn Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Prenatal Testing and Newborn Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Prenatal Testing and Newborn Screening players cover ILLUMINA, Natus Medical, PerkinElmer, Quest Diagnostics, Sequenom, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Prenatal Testing and Newborn Screening Industry Forecast” looks at past sales and reviews total world Prenatal Testing and Newborn Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Prenatal Testing and Newborn Screening sales for 2025 through 2031. With Prenatal Testing and Newborn Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prenatal Testing and Newborn Screening industry.
This Insight Report provides a comprehensive analysis of the global Prenatal Testing and Newborn Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prenatal Testing and Newborn Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prenatal Testing and Newborn Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prenatal Testing and Newborn Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prenatal Testing and Newborn Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Testing and Newborn Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Prenatal Testing
Newborn Screening
Segmentation by Application:
Hospitals
Pathology Labs
Gynecology Clinics
Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ILLUMINA
Natus Medical
PerkinElmer
Quest Diagnostics
Sequenom
Please note: The report will take approximately 2 business days to prepare and deliver.
Prenatal testing is performed on the mother during pregnancy. Newborn screening is performed after the baby is born.
United States market for Prenatal Testing and Newborn Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Prenatal Testing and Newborn Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Prenatal Testing and Newborn Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Prenatal Testing and Newborn Screening players cover ILLUMINA, Natus Medical, PerkinElmer, Quest Diagnostics, Sequenom, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Prenatal Testing and Newborn Screening Industry Forecast” looks at past sales and reviews total world Prenatal Testing and Newborn Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Prenatal Testing and Newborn Screening sales for 2025 through 2031. With Prenatal Testing and Newborn Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prenatal Testing and Newborn Screening industry.
This Insight Report provides a comprehensive analysis of the global Prenatal Testing and Newborn Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prenatal Testing and Newborn Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prenatal Testing and Newborn Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prenatal Testing and Newborn Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prenatal Testing and Newborn Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Testing and Newborn Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Prenatal Testing
Newborn Screening
Segmentation by Application:
Hospitals
Pathology Labs
Gynecology Clinics
Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ILLUMINA
Natus Medical
PerkinElmer
Quest Diagnostics
Sequenom
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
75 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Prenatal Testing and Newborn Screening Market Size by Player
- 4 Prenatal Testing and Newborn Screening by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Prenatal Testing and Newborn Screening Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.